MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202421006313 A) filed by Tata Consultancy Services Limited, Maharashtra, on Jan. 31, 2024, for 'method and system for delivery of optimal nasal drug deposition in a target region of nasal cavity.'
Inventor(s) include Jayaraman, Srinivasan; Ahmad, Dilshad; Purswani, Sushilkumar Leelaram; Maurya, Mithilesh Kumar; Kulkarni, Hrishikesh Nilkanth; and Beemaraj, Soban Babu.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "This disclosure relates generally to method and system for delivery of optimal nasal drug deposition in a target region of nasal cavity. Efficient delivery of nasal drug within a target region into the nasal cavity is challenging due to the structure of nostril lobe. The system obtains a nasal cavity CT scan of a subject, a breathing data of the subject, at least one target region of interest (ROI), and a scenario. The ML model selector triggers corresponding ML model to process the scenario among a plurality of scenarios to determine nasal drug particle deposition percentage of a nasal drug injected within the nasal cavity, or to determine drug parameters and or to design the device carrying the drug particle to transport the drug particle inside the nasal cavity. Additionally, the method creates an augmented reality visualization of the nasal drug particle movement inside the nasal cavity."
Disclaimer: Curated by HT Syndication.
